Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01341119
Other study ID # 2010-11-047
Secondary ID
Status Completed
Phase N/A
First received April 21, 2011
Last updated August 6, 2012
Start date November 2010

Study information

Verified date August 2012
Source Samsung Medical Center
Contact n/a
Is FDA regulated No
Health authority South Korea: Institutional Review Board
Study type Observational

Clinical Trial Summary

To study clinical features, prognostic factors and treatment outcome and to develop a possible prognostic index in skin/soft tissue primary NK/T cell lymphoma patients.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date
Est. primary completion date
Accepts healthy volunteers
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- histologically confirmed extranodal NK/T cell lymphoma

- primary site is skin or soft tissue

Exclusion Criteria:

- involvement of upper aerodigestive tract

Study Design

Observational Model: Cohort, Time Perspective: Retrospective


Locations

Country Name City State
Korea, Republic of Samsung Medical Center Seoul

Sponsors (1)

Lead Sponsor Collaborator
Samsung Medical Center

Country where clinical trial is conducted

Korea, Republic of, 

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05426824 - The Whole-course Management of Pegaspargase in ENKTL N/A